Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

TELESTA THERAPEUTICS INC T.TST

"Telesta Therapeutics Inc is a biopharmaceutical company. The Company is engaged in the research, development, manufacturing and commercialization of human health products and technologies."


TSX:TST - Post by User

Comment by IoftheLynchMobon Jul 24, 2014 1:09pm
244 Views
Post# 22778513

RE:RE:RE:Hopefully BNC is actively pursuing the NASDAQ listing...

RE:RE:RE:Hopefully BNC is actively pursuing the NASDAQ listing...superstar 

I held this stock for several years and sold, at a healthy loss not long after the Endo trial fell apart.  At the time I was astounded at how bad the valuation was. Not so much any more. Bioniche is a company that has crashed and burned and burned again at every opportunity to prosper and anyone who has owned it knows this.

i do like the get it done attitude of new management but much like their predecessors they seem clueless in delivering value to shareholders and communicating the message. You are correct in that there are a multitude of near term milestones but who is promoting this to the broader investment community? Apparently no one.

They have a vaccine Center on the block thatby all accounts is Global state of the art and carries a 60 mil replacement cost. That is a full 10 mil+ Greater than the current market cap. 

The market potential of MCC or whatever they call it now is probably North of 600 mil with off label and they are beyond a P3, they are days or weeks from an FDA endorsed submission for approval. that is well past the stage of a mere P3 and what can they drum up for it? 10 cents a share.essentially nothing.

I'll be stepping back at 24-25. Eventually someone will come along and kick open this bee hive and figure out what is really going on.



<< Previous
Bullboard Posts
Next >>